| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 401-410 |
| Journal | Cancer Biology and Therapy |
| Volume | 14 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2013 |
Cite this
}
Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells. / Wissing, M.D.; Mendonca, J.; Kim, E.; Shim, J.S.; Kaelber, N.S.; Kant, H.; Hammers, H.; Commes, T.; van Diest, P.J.; Liu, J.O.; Kachhap, S.K.
In: Cancer Biology and Therapy, Vol. 14, No. 5, 2013, p. 401-410.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells
AU - Wissing, M.D.
AU - Mendonca, J.
AU - Kim, E.
AU - Shim, J.S.
AU - Kaelber, N.S.
AU - Kant, H.
AU - Hammers, H.
AU - Commes, T.
AU - van Diest, P.J.
AU - Liu, J.O.
AU - Kachhap, S.K.
PY - 2013
Y1 - 2013
U2 - 10.4161/cbt.23759
DO - 10.4161/cbt.23759
M3 - Article
VL - 14
SP - 401
EP - 410
JO - Cancer Biology and Therapy
JF - Cancer Biology and Therapy
SN - 1538-4047
IS - 5
ER -